The phases of preclinical and clinical trials
Flexibility of the BLRM in Dose-Escalation Trials
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
![PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/17a2351e779a6f8131c6fa7a971a5f8a2dc17df2/7-Figure2-1.png "PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar")
PDF] Is the “3+3” Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design | Semantic Scholar
Dose Escalation Study Design Fictional Manuscript
On Biostatistics and Clinical Trials: Early Phase Trial to Find Maximal Tolerated Dose (MTD) - 3+3, CRM, and BOIN Designs
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma - ScienceDirect
Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol | BMJ Open
Phase 1 clinical trials: Designs and considerations
The Expansion Phase of Phase I Oncology Trials
Expansion Cohorts Guidance Balances Drug Development With Safety, Rigor
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial - The Lancet
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method | BMC Cancer | Full Text
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study | Semantic Scholar
Protocol B7861002 A PHASE 1 DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVENOUS P
Cancers | Free Full-Text | Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial
Early phase clinical trials Flashcards | Quizlet
The Classic 3 + 3 Design in Dose-finding Clinical Trials and Its Alternatives | Genpro Research
3 þ 3 Dose escalation study design for phase I clinical trials. DLT ¼... | Download Scientific Diagram
Early phase clinical trials to identify optimal dosing and safety - ScienceDirect
